Crescita Therapeutics Inc. (CRRTF.PK,CTX.TO), Monday announced its first-quarter financial results, reporting a net loss of C$1.160 million, or C$0.06 a share, compared to C$0.932 million, or C$0.05 a share, last year.
Operating loss amounted to C$1.2 million compared to C$1.1 million in the earlier year.
Revenues increased to C$5.6 million from C$3.5 million in the prior year.
Crescita's stock closed trading at $0.5731 on the OTC Markets on Friday.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.